These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37643353)

  • 41. Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.
    Wen Y; Graybill WS; Previs RA; Hu W; Ivan C; Mangala LS; Zand B; Nick AM; Jennings NB; Dalton HJ; Sehgal V; Ram P; Lee JS; Vivas-Mejia PE; Coleman RL; Sood AK
    Clin Cancer Res; 2015 Jan; 21(2):448-59. PubMed ID: 25416196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models.
    Kaweesa EN; Bazioli JM; Pierre HC; Lantvit DD; Kulp SK; Hill KL; Phelps MA; Coss CC; Fuchs JR; Pearce CJ; Oberlies NH; Burdette JE
    Mol Pharm; 2023 Jun; 20(6):3049-3059. PubMed ID: 37155928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhizoctonia bataticola lectin induces apoptosis and inhibits metastasis in ovarian cancer cells by interacting with CA 125 antigen differentially expressed on ovarian cells.
    Hegde P; B R S; Ballal S; Swamy BM; Inamdar SR
    Glycoconj J; 2021 Dec; 38(6):669-688. PubMed ID: 34748163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
    Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breaking the Iron Homeostasis: A "Trojan Horse" Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition.
    Li Y; Cen Y; Fang Y; Tang S; Li S; Ren Y; Zhang H; Lu W; Xu J
    ACS Nano; 2022 Aug; 16(8):12786-12800. PubMed ID: 35920396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3.
    Zou B; Wang H; Liu Y; Qi P; Lei T; Sun M; Wang Y
    Oncol Rep; 2017 Sep; 38(3):1431-1441. PubMed ID: 28714011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.
    Buensuceso A; Fritz JL; Collins O; Valdés YR; Borrelli MJ; DiMattia GE; Shepherd TG
    Sci Rep; 2022 Feb; 12(1):3011. PubMed ID: 35194062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SRT2183 impairs ovarian cancer by facilitating autophagy.
    Sun T; Hu Y; He W; Shang Y; Yang X; Gong L; Zhang X; Gong P; Yang G
    Aging (Albany NY); 2020 Nov; 12(23):24208-24218. PubMed ID: 33223507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PDCD1 strengthens the sensitivity of ovarian cancer to cisplatin chemotherapy by promoting apoptosis.
    Li Q; Gao JF; Qi BL
    J BUON; 2017; 22(3):746-756. PubMed ID: 28730785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancer.
    Liu B; Huang X; Li Y; Liao W; Li M; Liu Y; He R; Feng D; Zhu R; Kurihara H
    BMC Cancer; 2019 Jul; 19(1):645. PubMed ID: 31262254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells.
    Perez JM; Twigg CAI; Guan W; Thomas SN
    J Am Soc Mass Spectrom; 2022 Feb; 33(2):242-250. PubMed ID: 34958553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
    Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
    J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting.
    Bradbury A; O'Donnell R; Drew Y; Curtin NJ; Sharma Saha S
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32709004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells.
    Utaipan T; Athipornchai A; Suksamrarn A; Chunsrivirot S; Chunglok W
    Oncol Rep; 2017 Feb; 37(2):1243-1252. PubMed ID: 28075474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer.
    Shen YT; Wang L; Evans JC; Allen C; Piquette-Miller M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
    Dean M; Davis DA; Burdette JE
    Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
    Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
    Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer.
    Dasa SSK; Diakova G; Suzuki R; Mills AM; Gutknecht MF; Klibanov AL; Slack-Davis JK; Kelly KA
    Theranostics; 2018; 8(10):2782-2798. PubMed ID: 29774075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.